Implantable drug delivery device and methods
A method is provided for local controlled delivery of a drug to the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of a patient in need of treatment. In one embodiment, the method includes implanting a resorbable drug delivery device within the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of the patient. The drug delivery device may include an elastic device body housing at least one drug reservoir which contains at least one drug. In a preferred embodiment, the method further includes releasing the drug from the device in a controlled manner to, typically directly to, the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens.
1. An implantable medical device comprising:
a resorbable, elastic device body having a first closed end, an opposed second closed end, at least one elongated sidewall extending between the first and second closed ends, and at least one payload reservoir defined thereby; and
a payload stored in the payload reservoir,
wherein the device body provides controlled release of the payload in vivo by diffusion through the sidewall of the device body, and
wherein the implantable medical device is dimensioned and has an elasticity suitable for deployment of the medical device into a patient's bladder via the patient's urethra.
2. The device of claim 1 , wherein the device is deformable from a first configuration suited for passing the medical device through a lumen of a urethral catheter or cystoscope into the patient's bladder to a second configuration suited for retaining the device in the bladder upon exiting the urethral catheter or cystoscope.
3. The device of claim 1 , wherein the resorbable, elastic device body comprises an elastomeric polymer.
4. The device of claim 3 , wherein the elastomeric polymer is a hydrophobic elastomeric polyester.
5. The device of claim 4 , wherein the hydrophobic elastomeric polyester is a poly(glycerol-sebacic acid).
6. The device of claim 3 , wherein the elastomeric polymer comprises a poly(caprolactone), a polyanhydride, an amino alcohol-based poly(ester amide), or a poly(octane-diol citrate).
7. The device of claim 1 , wherein the payload comprises a drug.
8. The device of claim 7 , wherein the drug comprises an antibiotic agent, an immunosuppressant, an anti-inflammatory agent, a chemotherapeutic agent, or an anesthetic agent.
9. The device of claim 7 , wherein the payload is in a solid or semi-solid form.
10. The device of claim 1 , wherein the body comprises an elastic retention frame comprising a hoop, coil, or spiral shape configured to retain the device in the patient.
11. An implantable drug delivery device comprising:
a device body formed from a resorbable elastomeric polymer, the device body having an elongated annular sidewall defining a hollow bore; and
a payload consisting essentially of solid or semisolid drug loaded into the hollow bore,
wherein the device is deformable from a first configuration suited for passing the drug delivery device through a lumen of a urethral catheter or cystoscope into a patient's bladder to a second configuration suited for retaining the device in the bladder upon exiting the urethral catheter or cystoscope.
12. The device of claim 11 , wherein the resorbable elastomeric polymer comprises a hydrophobic elastomeric polyester which degrades in vivo by surface erosion.
13. The device of claim 11 , wherein the hydrophobic elastomeric polyester is a poly(glycerol-sebacic acid).
14. The device of claim 11 , wherein the body comprises an elastic retention frame comprising a hoop, coil, or spiral shape configured to retain the device in the patient.
15. The device of claim 1 , wherein the payload consists essentially of a drug.